MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Psychosis"

  • 2026 International Congress

    Depression and Psychosis in military Veterans with Parkinson’s Disease (PD)

    A. Sarwar, P. Bigner (Houston, USA)

    Objective: To compare the presence of co-morbid depression in groups of  PD Veterans, with and without psychosis. Background: Depression and psychosis are important non motor…
  • 2026 International Congress

    Delayed Parkinsonism in Anti‑NMDAR Encephalitis Following Immunotherapy – A Rare Clinical Manifestation

    C. Irawan, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: To describe a rare case of delayed parkinsonism emerging during the recovery phase of anti‑NMDAR encephalitis following immunotherapy in a young adult woman. Background:…
  • 2026 International Congress

    Clinical Outcome Assessments for Parkinson’s Disease Psychosis: A Systematic Review

    E. Camboe, S. Delray, MHS. Tosin, AJ. Noyce, C. Cooper (London, United Kingdom)

    Objective: To assess how well the content of clinical outcome assessments (COAs) for psychosis in Parkinson’s Disease (PD) aligns with the 2008 International Parkinson and Movement Disorders Society (MDS) Task Force guidance…
  • 2026 International Congress

    Face Pareidolia in the East London Parkinson’s Disease Project

    E. Camboe, KC. Dey, A. Zirra, S. Waters, E. Bhadra, R. Laban, B. Huxford, C. Simonet, C. Budu, DA. Gallagher, V. Azoidou, T. Boyle, C. Cooper, AJ. Noyce (London, United Kingdom)

    Objective: To determine the prevalence of pareidolic illusions in participants enrolled in the East London Parkinson’s Disease (ELPD) Project using the Noise Pareidolia Task (NPT),…
  • 2026 International Congress

    Remote Digital Deployment of a Validated Psychosis Screener in Parkinson’s Disease: Real-World Feasibility and Screening Yield

    A. Hare, S. Shaffer, B. Hood, R. Gilron (San Francisco, USA)

    Objective: To evaluate rapid remote deployment of the Self-Administered Screening Questionnaire for Parkinson's Disease-Associated Psychosis (SASPAP) and assess whether screening identifies unmet need for clinician…
  • 2026 International Congress

    Lack of Association Between Polygenic Risk Scores for Parkinson’s Disease and Age at Onset, Freezing of Gait, or Psychosis

    R. Shisgal, T. Davidy, A. Saar, S. Anis, T. Fay-Karmon, A. Sominski, M. Zhang, Z. Gan-Or, L. Grinbaum, S. Hassin-Baer (Ramat Gan, Israel)

    Objective: To evaluate whether the polygenic risk scores of Parkinson’s disease (PD-PRS) is associated with age at disease onset (AAO), freezing of gait (FOG) or…
  • 2025 International Congress

    Demographic Features, QTc Interval and Psychosis in Military Veterans with Parkinson’s disease (PD)

    A. Sarwar, P. Bigner (Houston, USA)

    Objective: To compare certain key demographic features and QTc intervals in groups of PD military Veterans with and without psychosis. Background: Psychosis is a disabling…
  • 2025 International Congress

    Refining the International Parkinson and Movement Disorder Society Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS): Cognitive Interview Results from an International Study

    M. Tosin, T. Mestre, G. Stebbins, G. Mangone, S. Videmsky, S. Ali, D. Aarsland, J. Goldman, T. Khoo, S. Lewis, P. Martinez-Martin, O. Ojo, J. Pagonabarraga, A. Schrag, D. Weintraub, C. Goetz (Chicago, USA)

    Objective: To assess the face and content validity of the International Parkinson and Movement Disorder Society Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS), a new under-developing Clinical…
  • 2025 International Congress

    Trends in U.S. Drug Use Among Hospitalized Parkinson’s Patients Experiencing Delirium

    H. Kamo, R. Burke, T. Mehta, M. Remz, M. Okun, C. Hess (Gainesvile, USA)

    Objective: To examine drug use trends among hospitalized Parkinson’s disease (PD) patients in the U.S. and to assess the association between PD medications and delirium.…
  • 2025 International Congress

    Predicting the Cognitive-Psychiatric Phenotype of Parkinson’s Disease

    H. Dhanis, J. Potheegadoo, S. Stampacchia, F. Bernasconi, C. Stucker, M. Maradan, L. Thanh, L. Jenni, J-A. Ghika, P. Burkhard, B. Vicki, D. Benninger, J. Horvath, P. Krack, D. de Ville, O. Blanke (Bern, Switzerland)

    Objective: Predict PD patient’s clinical scores from brain activity. Inform on which assessments capture true changes in cortical dynamics caused by PD and explain those…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 14
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley